LOTRONEX
NDC 54766-895, alosetron hydrochloride, tablet, from Sebela Pharmaceuticals Inc..
- Product NDC
- 54766-895
- Status
- Listed
- Labeler
- Sebela Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021107
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54766-895 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALOSETRON HYDROCHLORIDE1 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54766-895-03 | 54766089503 | 30 TABLET in 1 BOTTLE (54766-895-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/35cbb9d5-639b-207a-e054-00144ff88e88
Use it
Look up 54766-895 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54766-895 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54766-895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.